AIG
TARS icon

American International Group’s Tarsus Pharmaceuticals TARS Stock Holding History

American International Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,352
Closed -$522K – 2421
2024
Q1 		$522K Buy
14,352
+89
+0.6% +$2.62K ﹤0.01% 1626
2023
Q4 		$289K Buy
14,263
+2,496
+21% +$41.7K ﹤0.01% 1963
2023
Q3 		$209K Buy
11,767
+418
+4% +$7.4K ﹤0.01% 2096
2023
Q2 		$205K Buy
11,349
+2,479
+28% +$39.4K ﹤0.01% 2145
2023
Q1 		$111K Buy
8,870
+177
+2% +$2.59K ﹤0.01% 2408
2022
Q4 		$127K Sell
8,693
-32
-0.4% -$530 ﹤0.01% 2394
2022
Q3 		$149K Buy
8,725
+239
+3% +$3.79K ﹤0.01% 2333
2022
Q2 		$124K Buy
8,486
+4,300
+103% +$64.6K ﹤0.01% 2460
2022
Q1 		$70K Sell
4,186
-294
-7% -$5.46K ﹤0.01% 2730
2021
Q4 		$101K Sell
4,480
-134
-3% -$3.48K ﹤0.01% 2711
2021
Q3 		$99K Sell
4,614
-110
-2% -$2.72K ﹤0.01% 2814
2021
Q2 		$137 Buy
4,724
+1,098
+30% +$34.3K ﹤0.01% 2743
2021
Q1 		$117 Buy
3,626
+52
+1% +$1.92K ﹤0.01% 2637
2020
Q4 		$148 Buy
+3,574
New +$102K ﹤0.01% 2445

Other funds holding TARS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

American International Group's TARS Position: Q2 2024 in Review

American International Group sold out of Tarsus Pharmaceuticals (TARS) in Q2 2024, closing a stake of 14,352 shares — an estimated $522K sold.

American International Group first reported a position in TARS in Q4 2020 and held it in 14 quarters. The position peaked at $522K in Q1 2024. 148 funds tracked by Wall St. Rank hold TARS as of Q2 2024.

  • American International Group reported no remaining Tarsus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 14,352 Tarsus Pharmaceuticals shares in Q2 2024, an estimated $522K.
  • American International Group first reported a position in Tarsus Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • American International Group's Tarsus Pharmaceuticals position peaked at $522K in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.